A Study of KHK4827 (Brodalumab) in Subjects With Moderate to Severe Psoriasis in Korea
Clinical trial NCT02982005 · COMPLETED
Trial details
- NCT number
- NCT02982005
- Sponsor
- Kyowa Kirin Korea Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2018-08-14
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.